This report was recently updated on April 27 2024 with the latest and most recent
market numbers
Global Tissue Diagnostics Market Size, Trends & Analysis - Forecasts to 2029 By Technology (Immunohistochemistry, In-situ Hybridization, Primary & Special Staining, Digital Pathology & Workflow, and Anatomic Pathology), By Application (Breast Cancer, Non-small Cell Lung Cancer, Prostate Cancer, Gastric Cancer, and Other Cancers), By End-use (Hospitals, Research Laboratories, Pharmaceutical Organizations, and Contract Research Organizations (CROs)), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The global tissue-based diagnostics market is projected to grow at a CAGR of 8.5% from 2024 to 2029.
The tissue diagnostics market encompasses a range of tools, technology and services to analysis and diagnostics of diseases based on examination of tissue samples. The growing prevalence of cancer cases is the major factor contributing to the growth of tissue diagnostics market. According to World Health Organization, cancer is the global cause of death, responsible for almost 10 million deaths in 2020, constituting nearly one-sixth of all recorded deaths. The prevalent types of cancer include breast, colorectal, lung, and prostate cancers.
Emerging trends in tissue diagnostics market is also contributing to the anticipated growth, such as growing demand for precision healthcare. For example, in May 2021, QIAGEN has announced the expansion of companion diagnostic claims for its therascreen KRAS RGQ PCR Kit. QIAGEN is making testing with the therascreen KRAS Kit available immediately at leading laboratories across the U.S. through its Day-One Lab Readiness program for precision medicine.
The tissue diagnostics market is governed by rigorous regulations which are aimed at ensuring the safety, precision, and quality of diagnostic tests for the benefit of patient well-being. The procedures involved in securing regulatory approvals and complying with these standards can be time-consuming and expensive, especially in the case of new diagnostic technologies and companion diagnostics. The rigorous regulatory environment has the possibility to slow down the rate of innovation and hinder the entry of new products into the market.
Immunohistochemistry (IHC) segment is expected to hold the largest share of the market. Immunohistochemistry (IHC) is commonly preferred over traditional enzyme staining techniques because it has the capability to clearly distinguish variations among different types of tumors. In comparison to conventional methods that are limited in their ability to detect specific tumor tissue structures, enzymes, and proteins, IHC provides a more precise and nuanced approach for distinguishing between various tumor types.
Digital pathology & workflow segment is expected to be the fastest-growing segment in the market from 2024-2029. The growth of the segment is mainly due to a rising adoption of digital pathology solution such as whole-slide imaging (WSI) by pathologists. WSI is effective in extracting specific tumor features and quantifying each element, thereby aiding in cancer diagnosis and providing valuable clinical measures for tumors.
Breast cancer segment is expected to hold the largest share of the market. Increasing use of methods like immunohistochemistry and in situ hybridization which are used for precise analysis are driving the demand for tailored breast cancer diagnostic solutions and thus contributing to the segment growth. According to the World Health Organization, in 2020 around 2.3 million women were diagnosed with breast cancer and it caused around 685,000 deaths globally in 2020.
Prostate cancer segment is anticipated to be the fastest-growing segment in the market from 2024-2029. The anticipated growth of the market is due to advancements in genomic technologies leading which is leading to significant progress in discovering prostate cancer biomarkers. This, in turn, has supported the development of tissue diagnostic assays, which is contributing to the segment growth. Additionally, the launch of new product with advance technologies are also contributing to the growth of the market. For instance, in Mach 2023, Qritive, a provider of digital pathology solutions, has launched a new AI module named QAi Prostate for diagnosing prostate cancer.
The hospital segment holds the largest share of the market. This is due to extensive use of tissue diagnostic solutions and a shift towards efficient tissue-based testing methods in the hospitals. Medical professionals are progressively transitioning to tissue-based diagnostic testing methods as opposed to traditional procedures due to the time-saving benefits offered by tissue diagnostic tests in comparison to conventional methods.
The contract research organizations (CROs) segment is anticipated to be the fastest-growing segment in the market from 2024-2029. CROs offer research assistance, clinical trial services, and oversee trials and operations for entities dealing with budgetary limitations. The increased number of clinical trials and extensive research contributing in cancer therapy has notably boosted the demand for CRO services, leading to enhanced revenue generation within this segment.
North America is expected to be the largest region in the market. The primary reasons boosting the market growth in this region includes the established healthcare industry with increasing health care expenditure and rising demand for cancer diagnosis. Additionally, the rising cases of cancer in the North America region is another factor contributing to the market growth. As per the American Cancer Society's (ACS) 2021 and 2023 reports, the projected number of cancer cases rose from 1.91 million in 2021 to 1.96 million in 2023, indicating a surge of over 60 thousand cases in a two-year span.
Asia Pacific is predicted to witness rapid growth during the forecast period. The region growth is attributed to the increasing emerging trends of medical tourism in countries like India and China. Additionally, the rising healthcare expenditure of the region with growing countries economy is also expected to contribute in the regional market growth.
F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens, Danaher, bioMérieux SA, QIAGEN, BioGenex, Merck KGaA, and GE Healthcare among others, are some of the key players operating in the global tissue diagnostics market.
Please note: This is not an exhaustive list of companies profiled in the report.
In January 2023, Thermo Fisher Scientific has entered a global, multiyear partnership with AstraZeneca to develop a companion diagnostic (CDx) test for Tagrisso (osimertinib), aiming to identify non-small cell lung cancer (NSCLC) patients eligible for Tagrisso treatment based on specific epidermal growth factor receptor (EGFR) alterations.
In March 2023, Aptamer Group plc has introduced a novel reagent solution, Optimer-Fc, designed for automated immunohistochemistry (IHC) workflows. This development comes as the company collaborates with a top-three player in the IHC market to validate Optimer-Fc's performance in their automated IHC platform.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3 GLOBAL TISSUE DIAGNOSTICS MARKET OUTLOOK
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL TISSUE DIAGNOSTICS MARKET, BY APPLICATION
4.1 Introduction
4.2 Tissue Diagnostics Market: Application Scope Key Takeaways
4.3 Revenue Growth Analysis, 2023 & 2029
4.4 Breast Cancer
4.4.1 Breast Cancer Market Estimates and Forecast, 2021-2029 (USD Million)
4.5 Non-small Cell Lung Cancer
4.5.1 Non-small Cell Lung Cancer Market Estimates and Forecast, 2021-2029 (USD Million)
4.6 Prostate Cancer
4.6.1 Prostate Cancer Market Estimates and Forecast, 2021-2029 (USD Million)
4.7 Gastric Cancer
4.7.1 Gastric Cancer Market Estimates and Forecast, 2021-2029 (USD Million)
4.8 Other Cancers
4.8.1 Other Cancers Market Estimates and Forecast, 2021-2029 (USD Million)
5 GLOBAL TISSUE DIAGNOSTICS MARKET, BY END-USE
5.1 Introduction
5.2 Tissue Diagnostics Market: End-use Scope Key Takeaways
5.3 Revenue Growth Analysis, 2023 & 2029
5.4 Hospitals
5.4.1 Hospitals Market Estimates and Forecast, 2021-2029 (USD Million)
5.5 Research Laboratories
5.5.1 Research Laboratories Market Estimates and Forecast, 2021-2029 (USD Million)
5.6 Pharmaceutical Organizations
5.6.1 Pharmaceutical Organizations Market Estimates and Forecast, 2021-2029 (USD Million)
5.7 Contract Research Organizations (CROs)
5.7.1 Contract Research Organizations (CROs) Market Estimates and Forecast, 2021-2029 (USD Million)
6 GLOBAL TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY
6.1 Introduction
6.2 Tissue Diagnostics Market: Technology Scope Key Takeaways
6.3 Revenue Growth Analysis, 2023 & 2029
6.4 Immunohistochemistry
6.4.1 Immunohistochemistry Market Estimates and Forecast, 2021-2029 (USD Million)
6.5 In-s itu Hybridization
6.5.1 In Situ Hybridization Market Estimates and Forecast, 2021-2029 (USD Million)
6.6 Primary & Special Staining
6.6.1 Primary & Special Staining Market Estimates and Forecast, 2021-2029 (USD Million)
6.7 Digital Pathology and Workflow
6.7.1 Digital Pathology and Workflow Market Estimates and Forecast, 2021-2029 (USD Million)
6.8 Anatomic Pathology
6.8.1 Anatomic Pathology Market Estimates and Forecast, 2021-2029 (USD Million)
7 GLOBAL TISSUE DIAGNOSTICS MARKET, BY REGION
7.1 Introduction
7.2 North America Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.2.1 By Application
7.2.2 By End-use
7.2.3 By Technology
7.2.4 By Country
7.2.4.1 U.S. Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.2.4.1.1 By Application
7.2.4.1.2 By End-use
7.2.4.1.3 By Technology
7.2.4.2 Canada Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.2.4.2.1 By Application
7.2.4.2.2 By End-use
7.2.4.2.3 By Technology
7.2.4.3 Mexico Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.2.4.3.1 By Application
7.2.4.3.2 By End-use
7.2.4.3.3 By Technology
7.3 Europe Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.1 By Application
7.3.2 By End-use
7.3.3 By Technology
7.3.4 By Country
7.3.4.1 Germany Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.1.1 By Application
7.3.4.1.2 By End-use
7.3.4.1.3 By Technology
7.3.4.2 U.K. Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.2.1 By Application
7.3.4.2.2 By End-use
7.3.4.2.3 By Technology
7.3.4.3 France Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.3.1 By Application
7.3.4.3.2 By End-use
7.3.4.3.3 By Technology
7.3.4.4 Italy Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.4.1 By Application
7.3.4.4.2 By End-use
7.2.4.4.3 By Technology
7.3.4.5 Spain Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.5.1 By Application
7.3.4.5.2 By End-use
7.2.4.5.3 By Technology
7.3.4.6 Netherlands Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.6.1 By Application
7.3.4.6.2 By End-use
7.2.4.6.3 By Technology
7.3.4.7 Rest of Europe Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.3.4.7.1 By Application
7.3.4.7.2 By End-use
7.2.4.7.3 By Technology
7.4 Asia Pacific Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.1 By Application
7.4.2 By End-use
7.4.3 By Technology
7.4.4 By Country
7.4.4.1 China Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.1.1 By Application
7.4.4.1.2 By End-use
7.4.4.1.3 By Technology
7.4.4.2 Japan Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.2.1 By Application
7.4.4.2.2 By End-use
7.4.4.2.3 By Technology
7.4.4.3 India Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.3.1 By Application
7.4.4.3.2 By End-use
7.4.4.3.3 By Technology
7.4.4.4 South Korea Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.4.1 By Application
7.4.4.4.2 By End-use
7.4.4.4.3 By Technology
7.4.4.5 Singapore Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.5.1 By Application
7.4.4.5.2 By End-use
7.4.4.5.3 By Technology
7.4.4.6 Malaysia Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.6.1 By Application
7.4.4.6.2 By End-use
7.4.4.6.3 By Technology
7.4.4.7 Thailand Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.7.1 By Application
7.4.4.7.2 By End-use
7.4.4.7.3 By Technology
7.4.4.8 Indonesia Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.8.1 By Application
7.4.4.8.2 By End-use
7.4.4.8.3 By Technology
7.4.4.9 Vietnam Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.9.1 By Application
7.4.4.9.2 By End-use
7.4.4.9.3 By Technology
7.4.4.10 Taiwan Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.10.1 By Application
7.4.4.10.2 By End-use
7.4.4.10.3 By Technology
7.4.4.11 Rest of Asia Pacific Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.4.4.11.1 By Application
7.4.4.11.2 By End-use
7.4.4.11.3 By Technology
7.5 Middle East and Africa Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.5.1 By Application
7.5.2 By End-use
7.5.3 By Technology
7.5.4 By Country
7.5.4.1 Saudi Arabia Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.5.4.1.1 By Application
7.5.4.1.2 By End-use
7.5.4.1.3 By Technology
7.5.4.2 U.A.E. Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.5.4.2.1 By Application
7.5.4.2.2 By End-use
7.5.4.2.3 By Technology
7.5.4.3 Israel Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.5.4.3.1 By Application
7.5.4.3.2 By End-use
7.5.4.3.3 By Technology
7.5.4.4 South Africa Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.5.4.4.1 By Application
7.5.4.4.2 By End-use
7.5.4.4.3 By Technology
7.5.4.5 Rest of Middle East and Africa Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.5.4.5.1 By Application
7.5.4.5.2 By End-use
7.5.4.5.2 By Technology
7.6 Central and South America Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.6.1 By Application
7.6.2 By End-use
7.6.3 By Technology
7.6.4 By Country
7.6.4.1 Brazil Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.6.4.1.1 By Application
7.6.4.1.2 By End-use
7.6.4.1.3 By Technology
7.6.4.2 Argentina Eaporative Air Cooler Market Estimates and Forecast, 2021-2029 (USD Million)
7.6.4.2.1 By Application
7.6.4.2.2 By End-use
7.6.4.2.3 By Technology
7.6.4.3 Chile Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.6.4.3.1 By Application
7.6.4.3.2 By End-use
7.6.4.3.3 By Technology
7.6.4.4 Rest of Central & South America Tissue Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
7.6.4.4.1 By Application
7.6.4.4.2 By End-use
7.6.4.4.3 By Technology
8 COMPETITIVE LANDCAPE
8.1 Company Market Share Analysis
8.2 Four Quadrant Positioning Matrix
8.2.1 Market Leaders
8.2.2 Market Visionaries
8.2.3 Market Challengers
8.2.4 Niche Market Players
8.3 Vendor Landscape
8.3.1 North America
8.3.2 Europe
8.3.3 Asia Pacific
8.3.4 Rest of the World
8.4 Company Profiles
8.4.1 F. Hoffmann-La Roche Ltd.
8.4.1.1 Business Description & Financial Analysis
8.4.1.2 SWOT Analysis
8.4.1.3 Products & Services Offered
8.4.1.4 Strategic Alliances between Business Partners
8.4.2 Abbott Laboratories
8.4.2.1 Business Description & Financial Analysis
8.4.2.2 SWOT Analysis
8.4.2.3 Products & Services Offered
8.4.2.4 Strategic Alliances between Business Partners
8.4.3 Thermo Fisher Scientific Inc.
8.4.3.1 Business Description & Financial Analysis
8.4.3.2 SWOT Analysis
8.4.3.3 Products & Services Offered
8.4.3.4 Strategic Alliances between Business Partners
8.4.4 Siemens
8.4.4.1 Business Description & Financial Analysis
8.4.4.2 SWOT Analysis
8.4.4.3 Products & Services Offered
8.4.4.4 Strategic Alliances between Business Partners
8.4.5 Danaher
8.4.5.1 Business Description & Financial Analysis
8.4.5.2 SWOT Analysis
8.4.5.3 Products & Services Offered
8.4.5.4 Strategic Alliances between Business Partners
8.4.6 BioMérieux SA
8.4.6.1 Business Description & Financial Analysis
8.4.6.2 SWOT Analysis
8.4.6.3 Products & Services Offered
8.4.6.4 Strategic Alliances between Business Partners
8.4.7 QIAGEN
8.4.7.1 Business Description & Financial Analysis
8.4.7.2 SWOT Analysis
8.4.7.3 Products & Services Offered
8.4.8.4 Strategic Alliances between Business Partners
8.4.8 Merck KGaA
8.4.8.1 Business Description & Financial Analysis
8.4.8.2 SWOT Analysis
8.4.8.3 Products & Services Offered
8.4.8.4 Strategic Alliances between Business Partners
8.4.9 GE Healthcare
8.4.9.1 Business Description & Financial Analysis
8.4.9.2 SWOT Analysis
8.4.9.3 Products & Services Offered
8.4.9.4 Strategic Alliances between Business Partners
8.4.10 BioGenex
8.4.10.1 Business Description & Financial Analysis
8.4.10.2 SWOT Analysis
8.4.10.3 Products & Services Offered
8.4.10.4 Strategic Alliances between Business Partners
8.4.11 Other Companies
8.4.11.1 Business Description & Financial Analysis
8.4.11.2 SWOT Analysis
8.4.11.3 Products & Services Offered
8.4.11.4 Strategic Alliances between Business Partners
9 RESEARCH METHODOLOGY
9.1 Market Introduction
9.1.1 Market Definition
9.1.2 Market Scope & Segmentation
9.2 Information Procurement
9.2.1 Secondary Research
9.2.1.1 Purchased Databases
9.2.1.2 GMEs Internal Data Repository
9.2.1.3 Secondary Resources & Third Party Perspectives
9.2.1.4 Company Information Sources
9.2.2 Primary Research
9.2.2.1 Various Types of Respondents for Primary Interviews
9.2.2.2 Number of Interviews Conducted throughout the Research Process
9.2.2.3 Primary Stakeholders
9.2.2.4 Discussion Guide for Primary Participants
9.2.3 Expert Panels
9.2.3.1 Expert Panels Across 30+ Industry
9.2.4 Paid Local Experts
9.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
9.3 Market Estimation
9.3.1 Top-Down Approach
9.3.1.1 Macro-Economic Indicators Considered
9.3.1.2 Micro-Economic Indicators Considered
9.3.2 Bottom Up Approach
9.3.2.1 Company Share Analysis Approach
9.3.2.2 Estimation of Potential Product Sales
9.4 Data Triangulation
9.4.1 Data Collection
9.4.2 Time Series, Cross Sectional & Panel Data Analysis
9.4.3 Cluster Analysis
9.5 Analysis and Output
9.5.1 Inhouse AI Based Real Time Analytics Tool
9.5.2 Output From Desk & Primary Research
9.6 Research Assumptions & Limitations
9.7.1 Research Assumptions
9.7.2 Research Limitations
LIST OF TABLES
1 Global Tissue Diagnostics Market, By Application , 2021-2029 (USD Mllion)
2 Breast Cancer Market, By Region, 2021-2029 (USD Mllion)
3 Non-small Cell Lung Cancer Market, By Region, 2021-2029 (USD Mllion)
4 Prostate Cancer Market, By Region, 2021-2029 (USD Mllion)
5 Gastric Cancer Market, By Region, 2021-2029 (USD Mllion)
6 Other Cancers Market, By Region, 2021-2029 (USD Mllion)
7 Global Tissue Diagnostics Market, By End-use, 2021-2029 (USD Mllion)
8 Hospitals Market, By Region, 2021-2029 (USD Mllion)
9 Research Laboratories Market, By Region, 2021-2029 (USD Mllion)
10 Pharmaceutical Organizations Market, By Region, 2021-2029 (USD Mllion)
11 Contract Research Organizations (CROs) Market, By Region, 2021-2029 (USD Mllion)
12 Global Tissue Diagnostics Market, By Technology, 2021-2029 (USD Mllion)
13 Immunohistochemistry Market, By Region, 2021-2029 (USD Mllion)
14 In-Situ Hybridization Market, By Region, 2021-2029 (USD Mllion)
15 Primary & Special Staining Market, By Region, 2021-2029 (USD Mllion)
16 Digital Pathology and Workflow Market, By Region, 2021-2029 (USD Mllion)
17 Anatomic Pathology Market, By Region, 2021-2029 (USD Mllion)
18 Regional Analysis, 2021-2029 (USD Mllion)
19 North America Tissue Diagnostics Market, By Application , 2021-2029 (USD Million)
20 North America Tissue Diagnostics Market, By End-use, 2021-2029 (USD Million)
21 North America Tissue Diagnostics Market, By Technology, 2021-2029 (USD Million)
22 North America Tissue Diagnostics Market, By Country, 2021-2029 (USD Million)
23 U.S Tissue Diagnostics Market, By Application , 2021-2029 (USD Million)
24 U.S Tissue Diagnostics Market, By End-use, 2021-2029 (USD Million)
25 U.S Tissue Diagnostics Market, By Technology, 2021-2029 (USD Million)
26 Canada Tissue Diagnostics Market, By Application , 2021-2029 (USD Million)
27 Canada Tissue Diagnostics Market, By End-use, 2021-2029 (USD Million)
28 Canada Tissue Diagnostics Market, By Technology, 2021-2029 (USD Million)
29 Mexico Tissue Diagnostics Market, By Application , 2021-2029 (USD Million)
30 Mexico Tissue Diagnostics Market, By End-use, 2021-2029 (USD Million)
31 Mexico Tissue Diagnostics Market, By Technology, 2021-2029 (USD Million)
32 Europe Tissue Diagnostics Market, By Application , 2021-2029 (USD Million)
33 Europe Tissue Diagnostics Market, By End-use, 2021-2029 (USD Million)
34 Europe Tissue Diagnostics Market, By Technology, 2021-2029 (USD Million)
35 Europe Tissue Diagnostics Market, By country, 2021-2029 (USD Million)
36 Germany Tissue Diagnostics Market, By Application , 2021-2029 (USD Million)
37 Germany Tissue Diagnostics Market, By End-use, 2021-2029 (USD Million)
38 Germany Tissue Diagnostics Market, By Technology, 2021-2029 (USD Million)
39 U.K Tissue Diagnostics Market, By Application , 2021-2029 (USD Million)
40 U.K Tissue Diagnostics Market, By End-use, 2021-2029 (USD Million)
41 U.K Tissue Diagnostics Market, By Technology, 2021-2029 (USD Million)
42 France Tissue Diagnostics Market, By Application , 2021-2029 (USD Million)
43 France Tissue Diagnostics Market, By End-use, 2021-2029 (USD Million)
44 France Tissue Diagnostics Market, By Technology, 2021-2029 (USD Million)
45 Italy Tissue Diagnostics Market, By Application , 2021-2029 (USD Million)
46 Italy Tissue Diagnostics Market, By End Use , 2021-2029 (USD Million)
47 Italy Tissue Diagnostics Market, By Technology, 2021-2029 (USD Million)
48 Spain Tissue Diagnostics Market, By Application , 2021-2029 (USD Million)
49 Spain Tissue Diagnostics Market, By End-use, 2021-2029 (USD Million)
50 Spain Tissue Diagnostics Market, By Technology, 2021-2029 (USD Million)
51 Rest Of Europe Tissue Diagnostics Market, By Application , 2021-2029 (USD Million)
52 Rest Of Europe Tissue Diagnostics Market, By End-use, 2021-2029 (USD Million)
53 Rest of Europe Tissue Diagnostics Market, By Technology, 2021-2029 (USD Million)
54 Asia Pacific Tissue Diagnostics Market, By Application , 2021-2029 (USD Million)
55 Asia Pacific Tissue Diagnostics Market, By End-use, 2021-2029 (USD Million)
56 Asia Pacific Tissue Diagnostics Market, By Technology, 2021-2029 (USD Million)
57 Asia Pacific Tissue Diagnostics Market, By Country, 2021-2029 (USD Million)
58 China Tissue Diagnostics Market, By Application , 2021-2029 (USD Million)
59 China Tissue Diagnostics Market, By End-use, 2021-2029 (USD Million)
60 China Tissue Diagnostics Market, By Technology, 2021-2029 (USD Million)
61 India Tissue Diagnostics Market, By Application , 2021-2029 (USD Million)
62 India Tissue Diagnostics Market, By End-use, 2021-2029 (USD Million)
63 India Tissue Diagnostics Market, By Technology, 2021-2029 (USD Million)
64 Japan Tissue Diagnostics Market, By Application , 2021-2029 (USD Million)
65 Japan Tissue Diagnostics Market, By End-use, 2021-2029 (USD Million)
66 Japan Tissue Diagnostics Market, By Technology, 2021-2029 (USD Million)
67 South Korea Tissue Diagnostics Market, By Application , 2021-2029 (USD Million)
68 South Korea Tissue Diagnostics Market, By End-use, 2021-2029 (USD Million)
69 South Korea Tissue Diagnostics Market, By Technology, 2021-2029 (USD Million)
70 Vietnam Tissue Diagnostics Market, By Application , 2021-2029 (USD Million)
71 Vietnam Tissue Diagnostics Market, By End-use, 2021-2029 (USD Million)
72 Vietnam Tissue Diagnostics Market, By Technology, 2021-2029 (USD Million)
73 Rest of Asia Pacific Tissue Diagnostics Market, By Application , 2021-2029 (USD Million)
74 Rest of Asia Pacific Tissue Diagnostics Market, By End-use, 2021-2029 (USD Million)
75 Rest of Asia Pacific Tissue Diagnostics Market, By Technology, 2021-2029 (USD Million)
76 Middle East and Africa Tissue Diagnostics Market, By Application , 2021-2029 (USD Million)
77 Middle East and Africa Tissue Diagnostics Market, By End-use, 2021-2029 (USD Million)
78 Middle East and Africa Tissue Diagnostics Market, By Technology, 2021-2029 (USD Million)
79 Middle East and Africa Tissue Diagnostics Market, By Country, 2021-2029 (USD Million)
80 Saudi Arabia Tissue Diagnostics Market, By Application , 2021-2029 (USD Million)
81 Saudi Arabia Tissue Diagnostics Market, By End-use, 2021-2029 (USD Million)
82 Saudi Arabia Tissue Diagnostics Market, By Technology, 2021-2029 (USD Million)
83 UAE Tissue Diagnostics Market, By Application , 2021-2029 (USD Million)
84 UAE Tissue Diagnostics Market, By End-use, 2021-2029 (USD Million)
85 UAE Tissue Diagnostics Market, By Technology, 2021-2029 (USD Million)
86 South AfricaTissue Diagnostics Market, By Application , 2021-2029 (USD Million)
87 South AfricaTissue Diagnostics Market, By End-use, 2021-2029 (USD Million)
88 South AfricaTissue Diagnostics Market, By Technology, 2021-2029 (USD Million)
89 Rest of Middle East and AfricaTissue Diagnostics Market, By Application , 2021-2029 (USD Million)
90 Rest of Middle East and AfricaTissue Diagnostics Market, By End-use, 2021-2029 (USD Million)
91 Rest of Middle East and AfricaTissue Diagnostics Market, By Technology, 2021-2029 (USD Million)
92 Central and South America Tissue Diagnostics Market, By Application , 2021-2029 (USD Million)
93 Central and South America Tissue Diagnostics Market, By End-use, 2021-2029 (USD Million)
94 Central and South America Tissue Diagnostics Market, By Technology, 2021-2029 (USD Million)
95 Central and South America Tissue Diagnostics Market, By Country, 2021-2029 (USD Million)
96 Brazil Tissue Diagnostics Market, By Application , 2021-2029 (USD Million)
97 Brazil Tissue Diagnostics Market, By End-use, 2021-2029 (USD Million)
98 Brazil Tissue Diagnostics Market, By Technology, 2021-2029 (USD Million)
99 Chile Tissue Diagnostics Market, By Application , 2021-2029 (USD Million)
100 Chile Tissue Diagnostics Market, By End-use, 2021-2029 (USD Million)
101 Chile Tissue Diagnostics Market, By Technology, 2021-2029 (USD Million)
102 Rest of Central & South America Tissue Diagnostics Market, By Application , 2021-2029 (USD Million)
103 Rest of Central & South America Tissue Diagnostics Market, By End-use, 2021-2029 (USD Million)
104 Rest of Central & South America Tissue Diagnostics Market, By Technology, 2021-2029 (USD Million)
105 F. Hoffmann-La Roche Ltd.: Products & Services Offering
106 Abbott Laboratories: Products & Services Offering
107 Thermo Fisher Scientific Inc.: Products & Services Offering
108 Siemens: Products & Services Offering
109 Danaher: Products & Services Offering
110 BIOMÉRIEUX SA: Products & Services Offering
111 QIAGEN: Products & Services Offering
112 Merck KGaA: Products & Services Offering
113 GE Healthcare , Inc: Products & Services Offering
114 BioGenex: Products & Services Offering
115 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Tissue Diagnostics Market Overview
2 Global Tissue Diagnostics Market Value From 2021-2029 (USD Mllion)
3 Global Tissue Diagnostics Market Share, By Application (2023)
4 Global Tissue Diagnostics Market Share, By End-use (2023)
5 Global Tissue Diagnostics Market Share, By Technology (2023)
6 Global Tissue Diagnostics Market, By Region (Asia Pacific Market)
7 Technological Trends In Global Tissue Diagnostics Market
8 Four Quadrant Competitor Positioning Matrix
9 Impact Of Macro & Micro Indicators On The Market
10 Impact Of Key Drivers On The Global Tissue Diagnostics Market
11 Impact Of Challenges On The Global Tissue Diagnostics Market
12 Porter’s Five Forces Analysis
13 Global Tissue Diagnostics Market: By Application Scope Key Takeaways
14 Global Tissue Diagnostics Market, By Application Segment: Revenue Growth Analysis
15 Breast Cancer Market, By Region, 2021-2029 (USD Mllion)
16 Non-small Cell Lung Cancer Market, By Region, 2021-2029 (USD Mllion)
17 Prostate Cancer Market, By Region, 2021-2029 (USD Mllion)
18 Gastric Cancer Market, By Region, 2021-2029 (USD Mllion)
19 Other Cancers Market, By Region, 2021-2029 (USD Mllion)
20 Global Tissue Diagnostics Market: By End-use Scope Key Takeaways
21 Global Tissue Diagnostics Market, By End-use Segment: Revenue Growth Analysis
22 Hospitals Market, By Region, 2021-2029 (USD Mllion)
23 Research Laboratories Market, By Region, 2021-2029 (USD Mllion)
24 Pharmaceutical Organizations Market, By Region, 2021-2029 (USD Mllion)
25 Contract Research Organizations (CROs) Market, By Region, 2021-2029 (USD Mllion)
26 Global Tissue Diagnostics Market: By Technology Scope Key Takeaways
27 Global Tissue Diagnostics Market, By Technology Segment: Revenue Growth Analysis
28 Immunohistochemistry Market, By Region, 2021-2029 (USD Mllion)
29 In-situ Hybridization Market, By Region, 2021-2029 (USD Mllion)
30 Primary & Special Staining Market, By Region, 2021-2029 (USD Mllion)
31 Digital Pathology and Workflow Market, By Region, 2021-2029 (USD Mllion)
32 Anatomic Pathology Market, By Region, 2021-2029 (USD Mllion)
33 Regional Segment: Revenue Growth Analysis
34 Global Tissue Diagnostics Market: Regional Analysis
35 North America Tissue Diagnostics Market Overview
36 North America Tissue Diagnostics Market, By Application
37 North America Tissue Diagnostics Market, By End-use
38 North America Tissue Diagnostics Market, By Technology
39 North America Tissue Diagnostics Market, By Country
40 U.S. Tissue Diagnostics Market, By Application
41 U.S. Tissue Diagnostics Market, By End-use
42 U.S. Tissue Diagnostics Market, By Technology
43 Canada Tissue Diagnostics Market, By Application
44 Canada Tissue Diagnostics Market, By End-use
45 Canada Tissue Diagnostics Market, By Technology
46 Mexico Tissue Diagnostics Market, By Application
47 Mexico Tissue Diagnostics Market, By End-use
48 Mexico Tissue Diagnostics Market, By Technology
49 Four Quadrant Positioning Matrix
50 Company Market Share Analysis
51 F. Hoffmann-La Roche Ltd.: Company Snapshot
52 F. Hoffmann-La Roche Ltd.: SWOT Analysis
53 F. Hoffmann-La Roche Ltd.: Geographic Presence
54 Abbott Laboratories: Company Snapshot
55 Abbott Laboratories: SWOT Analysis
56 Abbott Laboratories: Geographic Presence
57 Thermo Fisher Scientific Inc.: Company Snapshot
58 Thermo Fisher Scientific Inc.: SWOT Analysis
59 Thermo Fisher Scientific Inc.: Geographic Presence
60 Siemens: Company Snapshot
61 Siemens: Swot Analysis
62 Siemens: Geographic Presence
63 Danaher: Company Snapshot
64 Danaher: SWOT Analysis
65 Danaher: Geographic Presence
66 BioMérieux SA: Company Snapshot
67 BioMérieux SA: SWOT Analysis
68 BioMérieux SA: Geographic Presence
69 QIAGEN: Company Snapshot
70 QIAGEN: SWOT Analysis
71 QIAGEN: Geographic Presence
72 Merck KGaA: Company Snapshot
73 Merck KGaA: SWOT Analysis
74 Merck KGaA: Geographic Presence
75 GE Healthcare , Inc.: Company Snapshot
76 GE Healthcare , Inc.: SWOT Analysis
77 GE Healthcare , Inc.: Geographic Presence
78 BioGenex: Company Snapshot
79 BioGenex: SWOT Analysis
80 BioGenex: Geographic Presence
81 Other Companies: Company Snapshot
82 Other Companies: SWOT Analysis
83 Other Companies: Geographic Presence
The Global Tissue Diagnostics Market has been studied from the year 2019 till 2029. However, the CAGR provided in the report is from the year 2024 to 2029. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Tissue Diagnostics Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
